Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2024

Genmab — Januar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • royalR Offline
    royalR Offline
    royal
    wrote on sidst redigeret af
    #65

    Har JnJ 40 milliarder til at købe for?

    1 Reply Last reply
    0
    • nohopeN Offline
      nohopeN Offline
      nohope
      wrote on sidst redigeret af
      #66

      Hviken slags milliarder ?

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #67

        Er vi så klar med "Ja-hatten" royal?

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #68

          "New Year’s Update and Outlook for My Epcoritamab Trial" https://cllsociety.org/2024/01/new-years-update-and-outlook-for-my-epcoritamab-trial/

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #69

            "It’s early, but all seven CLL patients in the European study of epcoritamab who were in complete remission, like me, also achieved undetectable MRD with flow cytometry down to 1 in 10,000 cells."

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #70

              "I may have been the first CLL patient in this trial, but I understand there is a significant waiting list for the trial now."

              1 Reply Last reply
              0
              • P Offline
                P Offline
                Plimsoller
                wrote on sidst redigeret af
                #71

                Nice and uplifting reading E L. Thank you for the link!

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gdn55
                  wrote on sidst redigeret af
                  #72

                  Også tak herfra

                  1 Reply Last reply
                  0
                  • royalR Offline
                    royalR Offline
                    royal
                    wrote on sidst redigeret af
                    #73

                    Dollar Nohope, og ja for filan, JKY_VH 🙂

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #74

                      Enig royal:-D

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #75

                        *NOVARTIS IN ADVANCED TALKS TO BUY CYTOKINETICS: WSJ $NVS

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          Pensionisten
                          wrote on sidst redigeret af
                          #76

                          Genmab handles pænt op i US . Lige nu i niveau 2224.

                          1 Reply Last reply
                          0
                          • M Offline
                            M Offline
                            Monforte
                            wrote on sidst redigeret af
                            #77

                            #EL, tillykke med din behandling og det gode resultat!

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #78

                              Good to hear your treatment succedeed EL Nice being shareholder to a co who created epco, dara etc 🙂

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #79

                                Worth more than money !

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #80

                                  i am not the patient here, just posting that blog; sorry if i confused that, i probalby shouldn't have copied that title directly....

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #81

                                    But now that we have you here Monforte, everything still going well for you?

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #82

                                      JPM24: Johnson & Johnson CEO says Tecvayli, Talvey and several other meds are set to trounce analyst estimates https://www.fiercepharma.com/pharma/jpm24-johnson-johnson-ceo-says-tecvayli-talvey-and-several-other-meds-can-vastly-outperform

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #83

                                        Hvis Carvykti slettes af listen i MM pga utilsigtede bivirkninger står Genmab godt og det kan være det JNJ forbereder investorerne på.Hvis JNJ taber voldgiften eller er interesseret i hexa-38 er der kun et alternativ for dem 😉

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #84

                                          Godmorgen 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper